| Gene: | BCL2A1 |
| GeneID: | ENSG00000140379 |
| Chrom: | 15 |
| Start position: | 79960892 |
| End position: | 79971196 |
| Pathway: | NF-kappa B signaling pathway |
| Class: | Environmental Information Processing; Signal transduction |
| FST gene level: | 0.0847805 |
| Number of nsSNPs: | 4 |
| nsSNPs in gene: | rs1138357 rs1138358 rs34080999 rs3826007 |
| Gene Structure: |  |
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
| Expression restricted in 1 cancer type(s) |
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
| Gscore (Amp): | 0.00 | | Gscore (Del): | 0.00 |
|
|
|
| |
|
|
|
| |
Overall distribution
|
|
Tissue specific distribution
|
| |
|
|
|
| |
|
|
|
| Functional class: | Not specified |
| JensenLab PubMed score: | 1146.15 (Percentile rank: 96.00%) |
| PubTator score: | 786.28 (Percentile rank: 95.59%) |
| Target development/druggability level: | TchemThese targets have activities in ChEMBL or DrugCentral that satisfy the activity thresholds detailed below. |
| Tractability (small molecule): | Clinical PrecedenceTargets with drugs in phase II or above; Pre-clinical targets |
| Tractability (antibody): | |